C T Ravirajan

1.2k citations
34 papers · 946 indexed · h-index 18

C T Ravirajan

34 papers receiving 927 citations

Peers

C T Ravirajan
Comparison fields: 5 of 59
  • Rheumatology 621
  • Immunology 624
  • Radiology, Nuclear Medicine and Imaging 416
  • Nephrology 112
  • Hematology 100
Replace Yoshiko Igarashi with:
Yoshiko Igarashi Japan
Mieke C.J. van Bruggen Netherlands
Juan Jakez-Ocampo Mexico
Ruth Fischel Israel
Rebecca Subang Canada
Z Awdeh United States
L Rönnblom Sweden
Mohamed R. Daha Netherlands
Wasilis Kolowos Germany
D Carthy United Kingdom
C T Ravirajan relative to Yoshiko Igarashi Japan Yoshiko Igarashi's profile →
Citations per field
00.5×2.9×
Yoshiko Igarashi · 1×
Citations per year

Countries citing papers authored by C T Ravirajan

Since Specialization
Citations

This map shows the geographic impact of C T Ravirajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C T Ravirajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C T Ravirajan more than expected).

Fields of papers citing papers by C T Ravirajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C T Ravirajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C T Ravirajan. The network helps show where C T Ravirajan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C T Ravirajan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C T Ravirajan Line = papers co-authored together C T Ravirajan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20114
2 20043
3 20042
4 200480
5 200441
6 20034
7 2002155
8 20023
9 200195
10 200017
11 199928
12 199910
13
Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
199838
14 199866
15 199718
16 199733
17 199646
18 19956
19 199514
20 199114

About C T Ravirajan

C T Ravirajan is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 34 papers that have together received 946 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (26 papers), Systemic Lupus Erythematosus Research (22 papers), T-cell and B-cell Immunology (18 papers), Renal Diseases and Glomerulopathies (5 papers), Immune Cell Function and Interaction (3 papers), Phagocytosis and Immune Regulation (2 papers), Platelet Disorders and Treatments (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Rheumatology (621 citations), Immunology (624 citations) and Radiology, Nuclear Medicine and Imaging (416 citations). C T Ravirajan has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include David Isenberg, Anisur Rahman, José Delgado Alves, Lee Stanyer, Paul R. J. Ames, Sean Donohue, Jatinderpal Kalsi, Lesley Mason, Chaim Putterman and Valerio Pittoni.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026